Affiliations: [a]
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
| [b]
University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada
| [c]
University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario, Canada
| [d]
Division of Neurology, Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada
| [e] School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
| [f] ICES, Toronto, Ontario, Canada
Correspondence:
[*]
Correspondence to: Dr. Kednapa Thavorn, Ottawa Hospital Research Institute, 501 ch. Smyth Rd., Box / C.P. 201B, Ottawa, Ontario K1H 8L6, Canada. E-mail: [email protected].
Note: [1] Co-senior authors.
Abstract: Background: Parkinson’s disease (PD) is a complex and debilitating condition that requires care from a multispecialty team. The Integrated Parkinson Care Network (IPCN) is an innovative pragmatic care model that focuses on integrated care, self-management support and technology-enabled care. Objective: This study aims to estimate the costs of the IPCN and assess whether benefits gained from the intervention offset its costs based on a single center experience. Methods: We conducted a return on investment (ROI) analysis of the IPCN from a societal perspective. The ROI for the IPCN was estimated as a ratio of the net savings and the intervention cost. The intervention cost was calculated as a sum of set-up and implementation costs. Cost savings was measured as the absolute reduction in the societal costs realized by PD patients. A positive ROI indicated that savings generated from the intervention offset its cost. Results: The total cost of the IPCN for 100 PD patients was C$135,669, or C$226 per patient per month. IPCN was associated with the reduction in societal cost of C$915 per patient per month (95%CI: –2,782, 951). The ROI per PD patient per month for the IPCN was 3.08 (95%CI: –0.60, 22.93), suggesting that for every C$1 invested in the IPCN, C$4.08 is gained through reduction in societal costs. The returns were greater among advanced PD patients. Conclusion: The IPCN has the potential to offer a good return on investment for PD patients, and its value for money is higher among advanced PD patients.
Keywords: Economic evaluation, Parkinson’s disease, integrated care, self-management support, technology-enabled care
